SNOA — Sonoma Pharmaceuticals Share News
0.000.00%
- $5.32m
- $0.12m
- $19.53m
Brief: Sonoma And Te Arai Launch Two New Microcyn Tech Products In Australia
Sonoma Pharma: Rises after Q1 revenue surges 66%
Brief: Sonoma Pharmaceuticals Reports Q1 EPS Of $0.54
Sonoma Pharma: Jumps as Boeing, British Aerospace clears disinfectant for usage
Brief: Sonoma Pharmaceuticals And Microsafe Group Say Microsafe® Disinfectant & Sanitizer Manufactured Using Sonoma's Microcyn Technology Successfully Passed Material Compatibility Testing For Both Airbus And Boeing Commercial Transport Aircraft
Brief: Sonoma Pharmaceuticals Reports Qtrly Loss Per Share Of $0.77
Brief: Sonoma Pharmaceuticals Files For Non Timely 10-K
Brief: Sonoma Pharmaceuticals Says Consolidating Most Of Corporate Functions In Offices In Woodstock, Georgia
U.S. STOCKS ON THE MOVE-Phio Pharma, Sonoma Pharma, Adaptimmune
U.S. STOCKS ON THE MOVE-Sonoma Pharma, Marinus Pharma, Party City
U.S. STOCKS ON THE MOVE-Sonoma Pharma, Jaguar Health, Zscaler
Sonoma Pharma: Surges after COVID-19 disinfectant approved in Australia
Brief: Sonoma Pharmaceuticals Receives COVID-19 label claim approval for Nanocyn disinfectant in Australia
Brief: Sonoma Pharmaceuticals Announces Expanded Distribution Deal With Brill International For Europe And Approval Of New CE Marking For Microdacyn60 Eye Care
Brief: Sonoma Pharmaceuticals Entered Into Agreement With Brill International
Brief: Sonoma Pharma Says Effective On April 14, Board Appointed Grant Edwards As New CFO
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:23 PM
NASDAQ RESUMED AT 11:25 AM
NASDAQ RESUMED AT 11:02 AM